This handout is for male infertility evaluation — chronic outpatient (azoospermia / oligospermia / asthenospermia / teratospermia / varicocele / hh / drug-induced / radiation). Your care team identified this based on: couple with ≥12 mo unprotected intercourse without conception (≥6 mo if female partner >35y) — male partner evaluation (aua 2020; eau; nice cg156).
Other reasons your team may use this plan: abnormal semen analysis per who 5th ed thresholds (volume, count, motility, morphology) (who 2010 5th); planned gonadotoxic therapy → sperm cryopreservation counseling (aua 2020; asrm); known azoospermia on prior testing — phenotyping (obstructive vs non-obstructive).
Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.
| Medication | Starting dose | How | When | What it does |
|---|---|---|---|---|
| Smoking cessation + alcohol moderation + marijuana cessation + heat avoidance + weight loss + anabolic steroid discontinuation | — | — | — | ASRM smoking + AUA 2020 + EAU; modifiable risk factors improve parameters in 3-6 mo |
Plan: Male infertility — AUA 2020 ladder: lifestyle → empiric → varicocele → ART → sperm retrieval → HH gonadotropin therapy
Contact your care team if any of the following happen:
Call 911 or go to the nearest emergency room right away if you have:
Coordinate with female partner workup; counseling for donor sperm / adoption if untreatable
Guideline: Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline — Part I evaluation (Schlegel PN et al, Fertil Steril/J Urol 2021 PMID 33309062) + Part II management (PMID 33309061). WHO laboratory semen-analysis reference values cited by name.